In IBD patients, ingested oral bacteria are believed to play a central role in disease pathogenesis by translocating to the lower digestive tract, where the pathobionts can evoke pathogenic immune responses by producing bacteria-reactive CD4+ T-cells62. This evidence concerns the gene CD4 and inflammatory bowel disease.